Press Releases

Year

Nov 2011

LifeVantage to Announce Fiscal First Quarter 2012 Results on November 14, 2011

SALT LAKE CITY , Nov. 7, 2011 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), makers of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced today it will release financial results for the fiscal first quarter ended September 30, 2011 , after the market closes on

PDF Version

Sep 2011

LifeVantage Announces Record Fiscal Year 2011 Results and Provides Fiscal Year 2012 Guidance

Record Fourth Quarter Net Revenue Increases to $15.0 Million
Generates Record Full Year Fiscal 2011 Operating Income of $3.7 Million
Company Strengthens Balance Sheet and Ends Fiscal 2011 with No Convertible Debt
Company Expects Fiscal Year 2012 Revenue and Operating Income to Increase Over 100%

PDF Version

Sep 2011

LifeVantage Announces That Donny Osmond Has Teamed With The Company As A Spokesperson for Protandim®, The Nrf2 Synergizer

Osmond Teams With Company After Taking Protandim At His Doctor's Suggestion And Experiencing Significant Health Benefits

PDF Version

Sep 2011

LifeVantage to Announce Fiscal Fourth Quarter and Full Year 2011 Results on September 28, 2011

LifeVantage to Announce Fiscal Fourth Quarter and Full Year 2011 Results on September 28, 2011 SALT LAKE CITY , Sept. 19, 2011 /PRNewswire/ -- LifeVantage Corporation (OTCBB:LFVN), makers of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced today it will release financial

PDF Version

Sep 2011

LifeVantage Announces Share Repurchase Program

Company authorized repurchase of up to $5 million in shares of its common stock

PDF Version

Aug 2011

LifeVantage to Present at Rodman & Renshaw Annual Global Investment Conference

LifeVantage to Present at Rodman & Renshaw Annual Global Investment Conference SALT LAKE CITY , Aug. 31, 2011 /PRNewswire/ -- LifeVantage Corporation (OTCBB: LFVN), makers of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced today that Douglas C.

PDF Version

Aug 2011

LifeVantage Announces Preliminary Record Fourth Quarter and Fiscal Year 2011 Results

LifeVantage Announces Preliminary Record Fourth Quarter and Fiscal Year 2011 Results SALT LAKE CITY , Aug. 25, 2011 /PRNewswire/ -- LifeVantage Corporation (OTCBB: LFVN), makers of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced preliminary results for the fourth quarter and

PDF Version

Jun 2011

LifeVantage Announces Leading Industry Scientists Strengthen Management Team and Scientific Advisory Board

Dr. Joe McCord Appointed Chief Scientific Officer and Dr. Brooks Hybertson Commits to Scientific Advisory Board

PDF Version

Jun 2011

LifeVantage Corporation to Present at Accredited Members Summer 2011 Investment Research Conference

LifeVantage Corporation to Present at Accredited Members Summer 2011 Investment Research Conference SAN DIEGO , June 9, 2011 /PRNewswire/ -- LifeVantage Corporation (OTCBB:LFVN) announced today that Douglas Robinson , the Company's President and Chief Executive Officer, and Carrie McQueen , the

PDF Version

Jun 2011

LifeVantage's Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article

LifeVantage's Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article SAN DIEGO , June 3, 2011 /PRNewswire/ -- LifeVantage Corporation (OTCBB: LFVN), the maker of Protandim®, a clinically demonstrated, science-based therapy for the reduction of oxidative stress by

PDF Version

Pagination

First page
Previous page
…
Page 30
Page 31
Page 32
Page 33
Current page 34
Page 35
Page 36
Page 37
Page 38
…
Next page
Last page